Digraph

2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteria
Antibiotic resistance – Swiss researchers make a breakthroughhttps://lenews.ch/2019/11/25/antibiotic-resistance-swiss-breakthrough/
2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteria
Chimeric peptidomimetic antibiotics against Gram-negative bacteria | Naturehttps://www.nature.com/articles/s41586-019-1665-6
2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteria
New Class of Antibiotics Disrupts Outer Membrane of Gram-Negative Bacteriahttps://www.contagionlive.com/news/new-class-of-antibiotics-disrupts-outer-membrane-of-gramnegative-bacteria
2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteriaGram-negative bacteria
New antibiotics target the outer membrane of bacteriahttps://www.nature.com/articles/d41586-019-03730-x
2019-10 A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteria2019-11 Study by an international collaboration on darobactin, a novel peptide with antibiotic propertiesDarobactinMRL-494Murepavadin
Polyphor presents AMR breaker - European Biotechnologyhttps://european-biotechnology.com/up-to-date/latest-news/news/polyphor-presents-amr-breaker.html
2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteriaOuter membrane protein targeting antibiotics (OMPTA)
Swiss take major step in fight against antimicrobial resistance | MENAFN.COMhttps://menafn.com/1099175548/Swiss-take-major-step-in-fight-against-antimicrobial-resistance
2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteria
UZH - Antibiotics with Novel Mechanism of Action Discoveredhttps://www.media.uzh.ch/en/Press-Releases/2019/Antibiotics.html
2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteria

Showing topic

2019-10 Chimeric peptidomimetic antibiotics against Gram-negative bacteria
Gram-negative bacteriaOuter membrane protein targeting antibiotics (OMPTA)